

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * cellular response to cadmium ion (GO:0071276) | 9.01716125 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 5.78555875 |
| 3 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.40997267 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.87114848 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.87114848 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.81044603 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.81044603 |
| 8 | * response to zinc ion (GO:0010043) | 4.76186060 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 4.56598789 |
| 10 | angiotensin maturation (GO:0002003) | 4.38483222 |
| 11 | eosinophil chemotaxis (GO:0048245) | 4.26671852 |
| 12 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.11225546 |
| 13 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.11225546 |
| 14 | regulation of mononuclear cell migration (GO:0071675) | 4.03683849 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.93199371 |
| 16 | vitamin biosynthetic process (GO:0009110) | 3.91491154 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 3.88880913 |
| 18 | exogenous drug catabolic process (GO:0042738) | 3.87503863 |
| 19 | drug catabolic process (GO:0042737) | 3.84870142 |
| 20 | eosinophil migration (GO:0072677) | 3.75302471 |
| 21 | regulation of cholesterol esterification (GO:0010872) | 3.73712365 |
| 22 | drug metabolic process (GO:0017144) | 3.65613320 |
| 23 | phospholipid efflux (GO:0033700) | 3.64086120 |
| 24 | ethanol oxidation (GO:0006069) | 3.60208902 |
| 25 | * response to cadmium ion (GO:0046686) | 3.59375127 |
| 26 | regulation of macrophage chemotaxis (GO:0010758) | 3.51023454 |
| 27 | complement activation, alternative pathway (GO:0006957) | 3.49593752 |
| 28 | fructose metabolic process (GO:0006000) | 3.47290946 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 3.40086797 |
| 30 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.37534194 |
| 31 | acute-phase response (GO:0006953) | 3.33820086 |
| 32 | plasma lipoprotein particle remodeling (GO:0034369) | 3.24268449 |
| 33 | protein-lipid complex remodeling (GO:0034368) | 3.24268449 |
| 34 | macromolecular complex remodeling (GO:0034367) | 3.24268449 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 3.21589077 |
| 36 | negative regulation of sterol transport (GO:0032372) | 3.21589077 |
| 37 | L-ascorbic acid metabolic process (GO:0019852) | 3.20738872 |
| 38 | oligosaccharide catabolic process (GO:0009313) | 3.19270300 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.18001032 |
| 40 | cholesterol efflux (GO:0033344) | 3.12863757 |
| 41 | reverse cholesterol transport (GO:0043691) | 3.11675114 |
| 42 | triglyceride homeostasis (GO:0070328) | 3.09974388 |
| 43 | acylglycerol homeostasis (GO:0055090) | 3.09974388 |
| 44 | indole-containing compound catabolic process (GO:0042436) | 3.06957633 |
| 45 | indolalkylamine catabolic process (GO:0046218) | 3.06957633 |
| 46 | tryptophan catabolic process (GO:0006569) | 3.06957633 |
| 47 | xenobiotic catabolic process (GO:0042178) | 3.04440576 |
| 48 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.95263720 |
| 49 | glycosphingolipid catabolic process (GO:0046479) | 2.94776687 |
| 50 | urea metabolic process (GO:0019627) | 2.93210925 |
| 51 | glucuronate metabolic process (GO:0019585) | 2.89264391 |
| 52 | uronic acid metabolic process (GO:0006063) | 2.89264391 |
| 53 | phenylpropanoid metabolic process (GO:0009698) | 2.88523071 |
| 54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.88434471 |
| 55 | nitrogen cycle metabolic process (GO:0071941) | 2.86990892 |
| 56 | vitamin D metabolic process (GO:0042359) | 2.85495725 |
| 57 | peptide hormone processing (GO:0016486) | 2.83287322 |
| 58 | glycolipid catabolic process (GO:0019377) | 2.82216340 |
| 59 | peptide catabolic process (GO:0043171) | 2.80310427 |
| 60 | glyoxylate metabolic process (GO:0046487) | 2.76921107 |
| 61 | amine catabolic process (GO:0009310) | 2.74602168 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 2.74602168 |
| 63 | bile acid metabolic process (GO:0008206) | 2.73822346 |
| 64 | urea cycle (GO:0000050) | 2.72449692 |
| 65 | regulation of guanylate cyclase activity (GO:0031282) | 2.72107302 |
| 66 | ethanol metabolic process (GO:0006067) | 2.70583011 |
| 67 | cellular glucuronidation (GO:0052695) | 2.69904531 |
| 68 | bile acid and bile salt transport (GO:0015721) | 2.67225983 |
| 69 | membrane lipid catabolic process (GO:0046466) | 2.63820070 |
| 70 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.61087160 |
| 71 | bile acid biosynthetic process (GO:0006699) | 2.60561100 |
| 72 | adhesion of symbiont to host cell (GO:0044650) | 2.59987540 |
| 73 | virion attachment to host cell (GO:0019062) | 2.59987540 |
| 74 | low-density lipoprotein particle remodeling (GO:0034374) | 2.59701309 |
| 75 | NADH metabolic process (GO:0006734) | 2.58832109 |
| 76 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.58680571 |
| 77 | sphingolipid catabolic process (GO:0030149) | 2.58486817 |
| 78 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.56287190 |
| 79 | heme transport (GO:0015886) | 2.55079793 |
| 80 | regulation of fibrinolysis (GO:0051917) | 2.53999967 |
| 81 | fat-soluble vitamin metabolic process (GO:0006775) | 2.51604252 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 2.51307186 |
| 83 | plasma lipoprotein particle organization (GO:0071827) | 2.50633969 |
| 84 | acute inflammatory response (GO:0002526) | 2.49687123 |
| 85 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.48089977 |
| 86 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.44909056 |
| 87 | lipoprotein metabolic process (GO:0042157) | 2.43600848 |
| 88 | aromatic amino acid family metabolic process (GO:0009072) | 2.43262024 |
| 89 | regulation of bile acid biosynthetic process (GO:0070857) | 2.43107654 |
| 90 | complement activation (GO:0006956) | 2.42449456 |
| 91 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.41985041 |
| 92 | intestinal absorption (GO:0050892) | 2.41873621 |
| 93 | ceramide catabolic process (GO:0046514) | 2.41836332 |
| 94 | regulation of oxidative phosphorylation (GO:0002082) | 2.41680016 |
| 95 | protein-lipid complex subunit organization (GO:0071825) | 2.41174438 |
| 96 | regulation of protein activation cascade (GO:2000257) | 2.39889271 |
| 97 | cellular ketone body metabolic process (GO:0046950) | 2.39368320 |
| 98 | complement activation, classical pathway (GO:0006958) | 2.37820823 |
| 99 | positive regulation of icosanoid secretion (GO:0032305) | 2.37805868 |
| 100 | * cellular response to zinc ion (GO:0071294) | 12.2330107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.49292307 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.43556044 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.19323744 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.02118939 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.96417308 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.89826365 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.78728712 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72367464 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.71681913 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.69601667 |
| 11 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.64236537 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.63191498 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38819746 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.33111279 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.28382670 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.27718963 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.23870493 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13380091 |
| 19 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.01344835 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.76464142 |
| 21 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.73952649 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72335514 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69819453 |
| 24 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.55567572 |
| 25 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.55382005 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53630391 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51376794 |
| 28 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.50423262 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.50234206 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42576987 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41952937 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37286239 |
| 33 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.36722333 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35084984 |
| 35 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.35081724 |
| 36 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.30136824 |
| 37 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27263887 |
| 38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26355485 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25106061 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21161195 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20121469 |
| 42 | SA1_27219007_Chip-Seq_Bcells_Human | 1.19914488 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19778906 |
| 44 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.19710405 |
| 45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16975000 |
| 46 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16677293 |
| 47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16296403 |
| 48 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.15037503 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13848652 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12824643 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12694649 |
| 52 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.11630261 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10170749 |
| 54 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.08253406 |
| 55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08231709 |
| 56 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07950604 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07688995 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06952567 |
| 59 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04821485 |
| 60 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04728871 |
| 61 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04115694 |
| 62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02148971 |
| 63 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.01940786 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01040520 |
| 65 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00371401 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98833928 |
| 67 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97960895 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97724185 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97447215 |
| 70 | CBP_21632823_ChIP-Seq_H3396_Human | 0.96210525 |
| 71 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.95692409 |
| 72 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95453106 |
| 73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94221533 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.92676973 |
| 75 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.92328975 |
| 76 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.92133859 |
| 77 | P300_27268052_Chip-Seq_Bcells_Human | 0.91597946 |
| 78 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90797929 |
| 79 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90776520 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.90180169 |
| 81 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.89636346 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89517452 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89269450 |
| 84 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.87942062 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86928117 |
| 86 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.86589440 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.86589440 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.85667392 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.85484752 |
| 90 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85247210 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84623746 |
| 92 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.84603081 |
| 93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83875721 |
| 94 | ERA_21632823_ChIP-Seq_H3396_Human | 0.83342617 |
| 95 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.83160385 |
| 96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.80975962 |
| 97 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.79881591 |
| 98 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.79342881 |
| 99 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.79290459 |
| 100 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79240313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.81149998 |
| 2 | MP0009840_abnormal_foam_cell | 4.20842538 |
| 3 | MP0003195_calcinosis | 4.13671573 |
| 4 | MP0005360_urolithiasis | 3.82808409 |
| 5 | MP0005365_abnormal_bile_salt | 3.66575996 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.10267148 |
| 7 | MP0004019_abnormal_vitamin_homeostasis | 2.93539435 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.88260315 |
| 9 | MP0009785_altered_susceptibility_to | 2.84177556 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.70209130 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.52706773 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.51668090 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.25950191 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.17905855 |
| 15 | MP0005332_abnormal_amino_acid | 2.16132467 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.07101950 |
| 17 | MP0003075_altered_response_to | 2.05826395 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 1.97578555 |
| 19 | MP0003879_abnormal_hair_cell | 1.90173212 |
| 20 | MP0006082_CNS_inflammation | 1.83756322 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.80659562 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.79279116 |
| 23 | MP0005166_decreased_susceptibility_to | 1.76334613 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.71222588 |
| 25 | MP0009764_decreased_sensitivity_to | 1.67835330 |
| 26 | MP0004510_myositis | 1.65841683 |
| 27 | MP0003436_decreased_susceptibility_to | 1.64277599 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.63670403 |
| 29 | MP0003011_delayed_dark_adaptation | 1.63248858 |
| 30 | MP0001764_abnormal_homeostasis | 1.54579345 |
| 31 | MP0000343_altered_response_to | 1.51208024 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.48964072 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.47850402 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.46646808 |
| 35 | MP0005025_abnormal_response_to | 1.46538870 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.42889680 |
| 37 | MP0002254_reproductive_system_inflammat | 1.39764006 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.39640962 |
| 39 | MP0008469_abnormal_protein_level | 1.39235254 |
| 40 | MP0005671_abnormal_response_to | 1.36638825 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.34604701 |
| 42 | MP0002419_abnormal_innate_immunity | 1.34493827 |
| 43 | MP0003690_abnormal_glial_cell | 1.31299150 |
| 44 | MP0010386_abnormal_urinary_bladder | 1.31007607 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.30939601 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.30117353 |
| 47 | MP0000604_amyloidosis | 1.27281020 |
| 48 | MP0001756_abnormal_urination | 1.26979291 |
| 49 | MP0002693_abnormal_pancreas_physiology | 1.24588296 |
| 50 | MP0001853_heart_inflammation | 1.21407099 |
| 51 | MP0003252_abnormal_bile_duct | 1.17197936 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.14688946 |
| 53 | MP0003186_abnormal_redox_activity | 1.13885797 |
| 54 | MP0001790_abnormal_immune_system | 1.13217546 |
| 55 | MP0005387_immune_system_phenotype | 1.13217546 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.12913364 |
| 57 | MP0000609_abnormal_liver_physiology | 1.08456563 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 1.07354079 |
| 59 | MP0005319_abnormal_enzyme/_coenzyme | 1.07239574 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.05994827 |
| 61 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.04905459 |
| 62 | MP0003868_abnormal_feces_composition | 1.02545883 |
| 63 | MP0005535_abnormal_body_temperature | 1.00220496 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.00109593 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 0.98910848 |
| 66 | MP0004043_abnormal_pH_regulation | 0.97823384 |
| 67 | MP0000920_abnormal_myelination | 0.97384818 |
| 68 | MP0005448_abnormal_energy_balance | 0.96173160 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.94456385 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.93008026 |
| 71 | MP0005310_abnormal_salivary_gland | 0.88983386 |
| 72 | MP0003300_gastrointestinal_ulcer | 0.88956381 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.88027030 |
| 74 | MP0001485_abnormal_pinna_reflex | 0.84775255 |
| 75 | MP0009642_abnormal_blood_homeostasis | 0.82329487 |
| 76 | MP0003866_abnormal_defecation | 0.82321739 |
| 77 | MP0003633_abnormal_nervous_system | 0.82172513 |
| 78 | MP0005670_abnormal_white_adipose | 0.81937347 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 0.81856977 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.81353392 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.80425480 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 0.79479535 |
| 83 | MP0000685_abnormal_immune_system | 0.78997855 |
| 84 | MP0009763_increased_sensitivity_to | 0.78013600 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 0.75151079 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.73301725 |
| 87 | MP0002090_abnormal_vision | 0.73261443 |
| 88 | MP0002723_abnormal_immune_serum | 0.72804238 |
| 89 | MP0009379_abnormal_foot_pigmentation | 0.71763591 |
| 90 | MP0002452_abnormal_antigen_presenting | 0.71566875 |
| 91 | MP0003953_abnormal_hormone_level | 0.71231680 |
| 92 | MP0001835_abnormal_antigen_presentation | 0.70596130 |
| 93 | MP0001944_abnormal_pancreas_morphology | 0.70575138 |
| 94 | MP0008004_abnormal_stomach_pH | 0.70354287 |
| 95 | MP0008874_decreased_physiological_sensi | 0.69042153 |
| 96 | MP0002064_seizures | 0.65972321 |
| 97 | MP0008872_abnormal_physiological_respon | 0.65558411 |
| 98 | MP0003303_peritoneal_inflammation | 0.64447931 |
| 99 | MP0002163_abnormal_gland_morphology | 0.62776290 |
| 100 | MP0003283_abnormal_digestive_organ | 0.62530562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.53677610 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 5.28523772 |
| 3 | Complement deficiency (HP:0004431) | 4.38191974 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.31980446 |
| 5 | Xanthomatosis (HP:0000991) | 3.88248994 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.86439231 |
| 7 | Malnutrition (HP:0004395) | 3.81396178 |
| 8 | Glomerulonephritis (HP:0000099) | 3.54200091 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.51824798 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.46216664 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.46216664 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.46216664 |
| 13 | Symptomatic seizures (HP:0011145) | 3.43751600 |
| 14 | Abnormality of complement system (HP:0005339) | 3.32586967 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.31460002 |
| 16 | Hydroxyprolinuria (HP:0003080) | 3.28286615 |
| 17 | Abnormality of proline metabolism (HP:0010907) | 3.28286615 |
| 18 | Hypoglycemic seizures (HP:0002173) | 3.14259453 |
| 19 | Generalized aminoaciduria (HP:0002909) | 3.08822435 |
| 20 | Prolonged partial thromboplastin time (HP:0003645) | 3.06406786 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.00788156 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 2.97112809 |
| 23 | Abnormality of macrophages (HP:0004311) | 2.94612721 |
| 24 | Abnormality of magnesium homeostasis (HP:0004921) | 2.89262340 |
| 25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.88382750 |
| 26 | Glycosuria (HP:0003076) | 2.81071715 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 2.81071715 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.64697387 |
| 29 | Late onset (HP:0003584) | 2.62678259 |
| 30 | Ketoacidosis (HP:0001993) | 2.62542185 |
| 31 | Hypomagnesemia (HP:0002917) | 2.59428533 |
| 32 | Fat malabsorption (HP:0002630) | 2.56952671 |
| 33 | Steatorrhea (HP:0002570) | 2.53564248 |
| 34 | Ketosis (HP:0001946) | 2.53358278 |
| 35 | Abnormality of vitamin B metabolism (HP:0004340) | 2.53119199 |
| 36 | Retinal atrophy (HP:0001105) | 2.46398642 |
| 37 | Hyperphosphaturia (HP:0003109) | 2.45921578 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.44711512 |
| 39 | Hypophosphatemia (HP:0002148) | 2.41505943 |
| 40 | Recurrent bacterial skin infections (HP:0005406) | 2.38616126 |
| 41 | Abnormality of vitamin metabolism (HP:0100508) | 2.37907352 |
| 42 | Hyperlipoproteinemia (HP:0010980) | 2.33681159 |
| 43 | Hyperglycemia (HP:0003074) | 2.33395851 |
| 44 | Nausea (HP:0002018) | 2.32428973 |
| 45 | Mitochondrial inheritance (HP:0001427) | 2.32076133 |
| 46 | Metaphyseal irregularity (HP:0003025) | 2.31131285 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.29682868 |
| 48 | Acute necrotizing encephalopathy (HP:0006965) | 2.28668902 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.26448161 |
| 50 | Abnormality of glycine metabolism (HP:0010895) | 2.26371600 |
| 51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.26371600 |
| 52 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.25369734 |
| 53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25021498 |
| 54 | Metabolic alkalosis (HP:0200114) | 2.24693003 |
| 55 | Irritability (HP:0000737) | 2.24595636 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.21205751 |
| 57 | Acute encephalopathy (HP:0006846) | 2.20988745 |
| 58 | Increased serum ferritin (HP:0003281) | 2.20612136 |
| 59 | Mutism (HP:0002300) | 2.20435112 |
| 60 | Hepatic necrosis (HP:0002605) | 2.19761811 |
| 61 | Vascular calcification (HP:0004934) | 2.17945555 |
| 62 | Deep venous thrombosis (HP:0002625) | 2.17863552 |
| 63 | Increased circulating renin level (HP:0000848) | 2.17373330 |
| 64 | Progressive macrocephaly (HP:0004481) | 2.16779424 |
| 65 | Hyperglycinuria (HP:0003108) | 2.14642052 |
| 66 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.13391335 |
| 67 | Nephritis (HP:0000123) | 2.12818780 |
| 68 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12646881 |
| 69 | Renal Fanconi syndrome (HP:0001994) | 2.12515767 |
| 70 | Prolonged neonatal jaundice (HP:0006579) | 2.11817379 |
| 71 | Purpura (HP:0000979) | 2.11582821 |
| 72 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10186532 |
| 73 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10186532 |
| 74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10186532 |
| 75 | Progressive neurologic deterioration (HP:0002344) | 2.08786858 |
| 76 | Lethargy (HP:0001254) | 2.07632693 |
| 77 | Tetany (HP:0001281) | 2.07465800 |
| 78 | Petechiae (HP:0000967) | 2.06918226 |
| 79 | Alkalosis (HP:0001948) | 2.05780535 |
| 80 | Megaloblastic anemia (HP:0001889) | 2.05152659 |
| 81 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.04135394 |
| 82 | Abnormal urine phosphate concentration (HP:0012599) | 2.02839946 |
| 83 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.01847053 |
| 84 | Hyperglycinemia (HP:0002154) | 2.00779064 |
| 85 | Widely patent fontanelles and sutures (HP:0004492) | 2.00092907 |
| 86 | Hypothermia (HP:0002045) | 1.98869925 |
| 87 | Axonal loss (HP:0003447) | 1.97665550 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 1.97094161 |
| 89 | Intrahepatic cholestasis (HP:0001406) | 1.96994617 |
| 90 | Joint hemorrhage (HP:0005261) | 1.95255793 |
| 91 | Loss of speech (HP:0002371) | 1.95017623 |
| 92 | Mucopolysacchariduria (HP:0008155) | 1.94875103 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94875103 |
| 94 | Hepatocellular necrosis (HP:0001404) | 1.94393581 |
| 95 | Cerebral edema (HP:0002181) | 1.92602428 |
| 96 | Hyperammonemia (HP:0001987) | 1.92551842 |
| 97 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91050006 |
| 98 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.90855058 |
| 99 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90699737 |
| 100 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90699737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 3.75857915 |
| 2 | MAP3K12 | 3.55138438 |
| 3 | TESK1 | 3.06474726 |
| 4 | MST4 | 2.91597925 |
| 5 | NME2 | 2.57719189 |
| 6 | RIPK4 | 2.34616729 |
| 7 | FRK | 2.18276070 |
| 8 | TESK2 | 2.12211058 |
| 9 | ERN1 | 2.09770904 |
| 10 | LIMK1 | 2.05216146 |
| 11 | PRKG2 | 2.02341204 |
| 12 | LMTK2 | 1.96958315 |
| 13 | PINK1 | 1.96119938 |
| 14 | STK16 | 1.94196379 |
| 15 | MAP3K11 | 1.88103221 |
| 16 | DAPK2 | 1.83797543 |
| 17 | KDR | 1.80465033 |
| 18 | TYK2 | 1.77088596 |
| 19 | OXSR1 | 1.76623622 |
| 20 | ABL2 | 1.75828735 |
| 21 | BLK | 1.71739518 |
| 22 | MAP2K6 | 1.67525162 |
| 23 | ADRBK2 | 1.67467751 |
| 24 | NTRK3 | 1.59635199 |
| 25 | MAP3K2 | 1.56829311 |
| 26 | WNK3 | 1.49835414 |
| 27 | DDR2 | 1.47713703 |
| 28 | TGFBR2 | 1.42356211 |
| 29 | MAP3K3 | 1.36953454 |
| 30 | GRK7 | 1.36489257 |
| 31 | MATK | 1.31975152 |
| 32 | DAPK1 | 1.28315236 |
| 33 | CSK | 1.28302280 |
| 34 | IKBKE | 1.27987019 |
| 35 | IRAK3 | 1.26033813 |
| 36 | MAP3K1 | 1.23529708 |
| 37 | TAOK1 | 1.19861189 |
| 38 | TNIK | 1.19045701 |
| 39 | NLK | 1.11099810 |
| 40 | VRK2 | 1.08872074 |
| 41 | INSRR | 1.05704437 |
| 42 | MAP4K1 | 1.04321435 |
| 43 | STK39 | 1.01741798 |
| 44 | TBK1 | 1.01307042 |
| 45 | PASK | 1.00058561 |
| 46 | IKBKB | 0.98601573 |
| 47 | FGR | 0.97738285 |
| 48 | GRK1 | 0.96177315 |
| 49 | BCKDK | 0.95572215 |
| 50 | TXK | 0.86569798 |
| 51 | TAOK3 | 0.85113226 |
| 52 | ARAF | 0.81382266 |
| 53 | CAMKK2 | 0.80127598 |
| 54 | PHKG2 | 0.79923803 |
| 55 | PHKG1 | 0.79923803 |
| 56 | PRKCG | 0.78424309 |
| 57 | MYLK | 0.77974517 |
| 58 | TNK2 | 0.77600253 |
| 59 | STK24 | 0.77300130 |
| 60 | CAMK2D | 0.75878945 |
| 61 | EPHA2 | 0.75245224 |
| 62 | FGFR2 | 0.68933417 |
| 63 | CSF1R | 0.68193534 |
| 64 | CAMK2G | 0.64754562 |
| 65 | LYN | 0.64350651 |
| 66 | MAP4K2 | 0.64215971 |
| 67 | PRKAA2 | 0.63309724 |
| 68 | PRKCA | 0.62977717 |
| 69 | PRKCI | 0.61808809 |
| 70 | ZAP70 | 0.59087990 |
| 71 | IRAK4 | 0.58015056 |
| 72 | TAOK2 | 0.56235213 |
| 73 | PAK4 | 0.55211006 |
| 74 | PAK3 | 0.54866682 |
| 75 | PRKCQ | 0.53249197 |
| 76 | PRKACG | 0.52287809 |
| 77 | MAPKAPK3 | 0.52201740 |
| 78 | PDPK1 | 0.48919417 |
| 79 | CSNK1A1 | 0.47839303 |
| 80 | CDC42BPA | 0.45601070 |
| 81 | NME1 | 0.44737920 |
| 82 | DAPK3 | 0.44026490 |
| 83 | FER | 0.41185295 |
| 84 | PRKCZ | 0.41101665 |
| 85 | JAK1 | 0.40683067 |
| 86 | PRKCD | 0.40539379 |
| 87 | BMPR2 | 0.39628634 |
| 88 | HIPK2 | 0.39192718 |
| 89 | PRKACA | 0.38981960 |
| 90 | CSNK1G1 | 0.37960936 |
| 91 | PDK1 | 0.37954251 |
| 92 | RIPK1 | 0.36538096 |
| 93 | BMX | 0.36147909 |
| 94 | EIF2AK3 | 0.33974668 |
| 95 | MAP3K9 | 0.33935231 |
| 96 | CSNK1G3 | 0.33050313 |
| 97 | PDK2 | 0.32773364 |
| 98 | WNK4 | 0.31071743 |
| 99 | PRKG1 | 0.31060369 |
| 100 | CAMK2A | 0.28890093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Mineral absorption_Homo sapiens_hsa04978 | 3.89807470 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.86573631 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.69837167 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.35094068 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.31770630 |
| 6 | Histidine metabolism_Homo sapiens_hsa00340 | 2.17784124 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.16845892 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.16787356 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.15324102 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.14477995 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03278178 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01726647 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98641222 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.97532537 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.95797490 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85583077 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.84587116 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.83897692 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75698392 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.72024596 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.70863979 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.69142021 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66342531 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58883097 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53695439 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53344993 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48826247 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45118397 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38481467 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.38422340 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37485101 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.37447823 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32671396 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.32316747 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32109091 |
| 36 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.31608954 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.29996319 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29945104 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26399681 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26365091 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24504735 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.22762919 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21179630 |
| 44 | Proteasome_Homo sapiens_hsa03050 | 1.20392572 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.13298879 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12516888 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.12292906 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07387160 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06765493 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.05087493 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03703376 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00295668 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98432311 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92565416 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89119851 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88694239 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88391406 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.87307284 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87071580 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84706212 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.84701988 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78516317 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76957649 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.75803034 |
| 65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.73541848 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70328105 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65611999 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65147056 |
| 69 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62742595 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61706215 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60837845 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.59899563 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.59666037 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58160181 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58000194 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57496409 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56909019 |
| 78 | Protein export_Homo sapiens_hsa03060 | 0.55173040 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55158468 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54452096 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54067932 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52601248 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45997688 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45959559 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44004916 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43797535 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.43502036 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42512051 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40286685 |
| 90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39874010 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39820560 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37752023 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.36731282 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35955631 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34353322 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32589035 |
| 97 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.30812714 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28769385 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.28140412 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.26972215 |

